| 除FDG以外的用于肿瘤PET显像的18F标记物 |
| |
| 引用本文： | 罗全勇. 除FDG以外的用于肿瘤PET显像的18F标记物[J]. 国际放射医学核医学杂志, 2001, 25(6): 249-253 |
| |
| 作者姓名： | 罗全勇 |
| |
| 作者单位： | 上海市第六人民医院核医学科,上海,200233 |
| |
| 摘 要： | 综述了除FDG以外的用于肿瘤PET显像的18F标记物的研究和应用.这些18F标记物主要包括与相应受体结合的18F标记的蛋白质和多肽,18F标记的乏氧显像剂,用于评价基因治疗的18F标记物等.此外,还介绍了用于诊断不同恶性肿瘤的18F标记的组织特异性PET显像剂.
|
| 关 键 词： | 正电子发射断层显像 18F标记物 肿瘤学 |
| 文章编号： | 1001-098X(2001)06-0249-05 |
| 修稿时间： | 2001-03-16 |
18F-labeled radiopharmaceuticals (excluding FDG) for PET in oncology |
| |
| LUO Quan-yong. 18F-labeled radiopharmaceuticals (excluding FDG) for PET in oncology[J]. International Journal of Radiation Medicine and Nuclear Medicine, 2001, 25(6): 249-253 |
| |
| Authors: | LUO Quan-yong |
| |
| Abstract: | This article reviews possible use of 18 F labeled radiopharmaceuticals(excluding FDG) in oncology with positron emission tomography. The characteristics of various 18 F labeled compounds are proteins and peptides, those that bind to receptors, agents to assess hypoxia, and agents to evaluate gene therapy. Furthermore, different 18 F labeled tissue specific agents are indicated for the detection and monitoring of various malignancies. |
| |
| Keywords: | positron emission tomography 18 F labeled compound oncology |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
